Page 131 - NobleCon21

Nutriband Inc.

SELECTED FINANCIAL ITEMS NTRB
(in millions of USD)
CQ4 '24 CQ1 '25 CQ2 '25 CQ3 '25 LTM
Income Statement Key Items
Total Revenue 0.65 0.64 0.67 0.62 2.58
Gross Profit 0.19 0.29 0.25 0.16 0.89
Gross Margin 30% 45% 38% 25% 34%
EBIT (1.43) (1.96) (1.41) (2.00) (6.81)
EBIT Margin -221% -306% -212% -322% -264%
Net Income to Common Shareholders (1.36) (5.52) (1.39) (2.00) (10.27)
Net Margin -211% -859% -208% -321% -398%

Balance Sheet Key Items
Total Assets 12.54 7.47 6.15 10.18 10.18
Cash & Short Term Investments 5.70 4.31 2.96 7.00 7.00
% of Assets 45% 58% 48% 69% 69%
Current Assets -Total 6.19 4.79 3.43 7.52 7.52
% of Assets 49% 64% 56% 74% 74%
Total Liabilities 1.31 1.04 1.05 1.68 1.68
% of Assets 10% 14% 17% 17% 17%
Current Liabilities - Total 1.25 0.98 0.93 1.57 1.57
% of Assets 10% 13% 15% 15% 15%
Long Term Debt 0.06 0.06 0.05 0.05 0.05
% of Assets 1% 1% 1% 0% 0%
Total Equity 11.23 6.43 5.10 8.49 8.49
% of Assets 90% 86% 83% 83% 83%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (1.01) (1.24) (1.34) (1.31) (4.90)
Net Cash Flow - Investing (0.05) 0.00 (0.01) 0.00 (0.05)
Net Cash Flow - Financing (0.01) (0.15) (0.01) 5.34 5.19

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference